Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatitis B × Lymphoid × Clear all

Phase

Phase 4 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Gynecologic 1 Gastrointestinal 1

Conditions

Lymphoma 182 Lymphoma, Follicular 179 Lymphoma, Non-Hodgkin 152 Lymphoma, Large B-Cell, Diffuse 148 Leukemia, Lymphocytic, Chronic, B-Cell 144 Precursor Cell Lymphoblastic Leukemia-Lymphoma 139 Leukemia 81 Hodgkin Disease 81 Lymphoma, Mantle-Cell 70 Burkitt Lymphoma 59 Lymphoma, B-Cell, Marginal Zone 57 Leukemia, Myeloid, Acute 50 Multiple Myeloma 46 Lymphoma, Large-Cell, Immunoblastic 43 Recurrence 39 Myelodysplastic Syndromes 35 Lymphoma, T-Cell, Cutaneous 33 Neoplasms 32 Lymphoma, Large-Cell, Anaplastic 28 Mycosis Fungoides 26 Waldenstrom Macroglobulinemia 24 Leukemia, Myeloid, Chronic-Phase 24 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 23 Myeloproliferative Disorders 23 Leukemia, Myeloid, Accelerated Phase 23 Sezary Syndrome 22 Lymphoma, B-Cell 22 Neoplasms, Plasma Cell 21 Immunoblastic Lymphadenopathy 21 Blast Crisis 21

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown

Hepatitis B, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡